Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revive Therapeutics Ltd
(OP:
RVVTF
)
0.0110
-0.0010 (-8.33%)
Streaming Delayed Price
Updated: 3:23 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Revive Therapeutics Ltd
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Marijuana & Psychedelic Drug Stocks Continue To Decline
January 16, 2022
The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...
Via
Talk Markets
Marijuana & Psychedelic Compounds-Based Drug Stocks Now Down -16% YTD
December 17, 2021
A look at which index has done the best so far in December: the Marijuana Drug Stocks Index or the Psychedelic Compounds-Based Drug Stocks Index.
Via
Talk Markets
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
December 01, 2021
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Detroit Decriminalizes Psychedelics
Via
Benzinga
Exposures
Product Safety
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
April 20, 2021
In recent years, there has been a re-emergence in the study of psychedelic drug...
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
September Summary: Cannabis-Based Vs. Psychedelic Compounds-Based Drug Stock Performances
October 01, 2021
Which index out-performed in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September
September 20, 2021
Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week
September 11, 2021
The performance of the psychedelic-focused index components substantially outshone the weed stocks.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Marijuana Drug Stocks: All You Need To Know Is Here!
August 13, 2021
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
October 05, 2021
Palm Beach, FL – October 5, 2021 – FinancialNewsMedia.com News Commentary – The psychedelic drugs market is creating major potential for treatment of mental illnesses, and as a result, it is likely to...
Via
FinancialNewsMedia
These OTC Securities Had the Most Trading Activity in July
August 06, 2021
Photo by Federico Beccari on Unsplash In July, O...
Via
Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Marijuana And Mushroom Stock Category Down 4% In July; Now +24% YTD
August 01, 2021
We detail how he pot- and psychedelic-related stock sector performed in the last week, during the month of July, and YTD and the stocks that moved +/-5% last week, and why.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison
July 24, 2021
We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD.
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Pot Stocks Down In June - Remain +29.6% YTD
July 04, 2021
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
The Cannabis-Centric BioPharma Stocks Index Declined In April But Remains Up YTD
May 05, 2021
13 cannabis-centric clinical-stage biopharmaceutical companies and their major operational activities in April to assist those considering investing in this marijuana sub-category,
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week
April 26, 2021
41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price.
Via
Talk Markets
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
April 25, 2021
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.
Via
Talk Markets
Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week
April 17, 2021
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change.
Via
Talk Markets
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
April 14, 2021
Via
FinancialNewsMedia
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.